Proposed Law Limits Rx

Senate Bill 129, introduced January 10, limits a practitioner from prescribing more than a seven-day supply of a Schedule II or Schedule III controlled substance for a patient upon the initial consultation or treatment of the patient for acute pain.

The bill defines “acute pain” to mean pain, whether resulting from disease, accidental or intentional trauma, or other causes, that is reasonably expected to last only a short or finite period of time.  The term does not include chronic pain, or pain being treated as part of cancer care, hospice or other end of live care.

After issuing the initial prescription and evaluating the patient’s condition, the practitioner may issue any appropriate renewal, refill or new prescription for the controlled substance or another drug for the patient.